Related Experiment Video
Updated: May 28, 2026

A Practical Guide to Phylogenetics for Nonexperts
Published on: February 5, 2014
SPIn: model selection for phylogenetic mixtures via linear invariants
A M Kedzierska1, M Drton, R Guigó
1Bioinformatics and Genomics Group, Centre for Genomic Regulation (CRG) and UPF, Barcelona, Catalonia, Spain.
Abstract:
In phylogenetic inference, an evolutionary model describes the substitution processes along each edge of a phylogenetic tree. Misspecification of the model has important implications for the analysis of phylogenetic data. Conventionally, however, the selection of a suitable evolutionary model is based on heuristics or relies on the choice of an approximate input tree. We introduce a method for model Selection in Phylogenetics based on linear INvariants (SPIn), which uses recent insights on linear invariants to characterize a model of nucleotide evolution for phylogenetic mixtures on any number of components. Linear invariants are constraints among the joint probabilities of the bases in the operational taxonomic units that hold irrespective of the tree topologies appearing in the mixtures. SPIn therefore requires no input tree and is designed to deal with nonhomogeneous phylogenetic data consisting of multiple sequence alignments showing different patterns of evolution, for example, concatenated genes, exons, and/or introns. Here, we report on the results of the proposed method evaluated on multiple sequence alignments simulated under a variety of single-tree and mixture settings for both continuous- and discrete-time models. In the simulations, SPIn successfully recovers the underlying evolutionary model and is shown to perform better than existing approaches.
Related Concept Videos
Genetics of Speciation
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Applications of Molecular Taxonomy
Phylogenetic Trees
Phylogenetic Trees
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

